ASCO 2019 Roundup: A Year for Twitter
By Karen Gehrman | cancer.ucsf.edu | June 14, 2019
Once again UCSF had an impressive presence at this year's annual meeting of the American Society of Clinical Oncologists (ASCO) in Chicago. One of the world’s most prestigious gatherings of oncology professionals, ASCO 2019 drew more than 40,000 cancer experts focusing on groundbreaking research and advances in cancer with the theme of Caring for Every Patient, Learning From Every Patient.
HDFCCC members and junior faculty presented a range of cancer research from UCSF. Sixty-four of the HDFCCC’s 400+ members were represented in abstracts accepted for presentation. ASCO provides investigators of all levels a chance to present and review research, confer with colleagues, and return with new ideas. In addition to attending keynotes, oral abstract presentations, posters presentations, and a variety of special events, attendees discuss and debate over social media. Some of the highlights are noted below.
Notable HonorsDr. Li-Wen Huang was awarded the 2019 Conquer Cancer Foundation of the American Society of Clinical Oncology first Endowed Young Investigator Award in Geriatric Oncology in honor of Dr. Arti Hurria for her project titled “Understanding the Relationship Between Frailty and Cognitive Decline After Allogeneic Stem Cell Transplantation in Older Adults” with her mentors Dr. Michael Steinman and Dr. Rebecca Olin.
Alan Venook, MD, was one of 15 cancer researchers acknowledged with a Giants of Cancer Care Award by OncLive.
UCSF at #ASCO19
Twitter usage remains hight at ASCO, demonstrating the increasing role of social media in the dissemination of findings at conferences. While many of our researchers were engaging with colleagues, others were promoting the work of junior faculty, or team members. Online news channels such as @oncologytube @ascopost conducted interviews with industry experts specifically for distribution on social media due to the large volume of traffic. Industry partners, and patient advocates are taking more of a role.
RT @MCR_AACR: Rapid Impact from Aggarwal @UCSFCancer and colleagues: Inter- and intra-patient heterogeneity highlights the complexity of managing treatment-emergent small cell neuroendocrine #prostatecancer.https://t.co/FvlBLymw8m pic.twitter.com/p8OSszF0cG— AACR (@AACR) June 4, 2019
HDFCCC Communications Generating a Buzz
Our communications team was on hand to promote and amplify UCSF participation.
PHACT news! There’s time to visit Mallika Dhawan at poster board 25 to talk about the feasibility of #cancerrisk screening in large multiethnic populations. Hint: with costs coming down, it’s becoming more feasible. #PopulationHealth and #cancer testing #ASCO19 @bernmunster # pic.twitter.com/xhG5ZPrGMg— UCSF Cancer Center (@UCSFCancer) June 3, 2019
Run, don’t walk to find out what @s_brond has to say about the feasibility of implementing a resident #oncology video curriculum #asco19 #asco2019 we’ll save you a seat #meded #MedTwitter #ascotrainee pic.twitter.com/K8yetNyuh0— UCSF Cancer Center (@UCSFCancer) June 3, 2019
YouTube: Capturing Highlights from Key Findings
Dr. Joel Palefsky was one of several UCSF faculty members chairing key educational sessions at ASCO. The Management and Prevention of Anal Squamous Cell Carcinoma Cancer discusses topics such as prevention through HPV vaccination as well as treatment and symptom management issues related to anal cancer
Dr. Hope Rugo reported on findings from the discuss findings from the SOPHIA trial on margetuximab plus chemotherapy vs trastuzumab plus chemotherapy in patients with HER2-positive metastatic breast cancer after prior anti-HER2 therapies.
For more specifics, watch as Dr. Rugo addresses the ASCO Post more about the SOPHIA study.
Dr. Nina Shah offered her insights on the latest presentations on multiple myeloma clinical trial results.
Dr. Mallika Dhawan reported on results from the PHACT Study on Population Health and Cancer Testing.